(25R)-26-O-beta-D-glucopyranosyl-furost-5-ene-1beta,3beta,22alpha,26-tetrol-1-O-alpha-L-rhamnopyranosyl-(1→2)-[beta-D-xylopyranosyl-(1→3)]-alpha-L-arabinopyranoside - Compound Card

(25R)-26-O-beta-D-glucopyranosyl-furost-5-ene-1beta,3beta,22alpha,26-tetrol-1-O-alpha-L-rhamnopyranosyl-(1→2)-[beta-D-xylopyranosyl-(1→3)]-alpha-L-arabinopyranoside

Select a section from the left sidebar

(25R)-26-O-beta-D-glucopyranosyl-furost-5-ene-1beta,3beta,22alpha,26-tetrol-1-O-alpha-L-rhamnopyranosyl-(1→2)-[beta-D-xylopyranosyl-(1→3)]-alpha-L-arabinopyranoside

Structure
Zoomed Structure
  • Family: Plantae - Dracaenaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Steroidal Saponin
Canonical Smiles OCC1OC(OC(CC[C@@]2(O)OC3C([C@@H]2C)[C@@]2(C(C3)C3CC=C4[C@](C3CC2)(C)[C@@H](C[C@@H](C4)O)OC2OCC(C(C2OC2OC(C)C(C(C2O)O)O)OC2OCC(C(C2O)O)O)O)C)C)C(C(C1O)O)O
InChI InChI=1S/C48H78O22/c1-18(64-43-39(60)36(57)34(55)29(15-49)66-43)8-11-48(61)19(2)31-28(70-48)14-25-23-7-6-21-12-22(50)13-30(47(21,5)24(23)9-10-46(25,31)4)67-45-41(69-44-38(59)35(56)32(53)20(3)65-44)40(27(52)17-63-45)68-42-37(58)33(54)26(51)16-62-42/h6,18-20,22-45,49-61H,7-17H2,1-5H3/t18?,19-,20?,22+,23?,24?,25?,26?,27?,28?,29?,30+,31?,32?,33?,34?,35?,36?,37?,38?,39?,40?,41?,42?,43?,44?,45?,46-,47-,48+/m0/s1
InChIKey YDGMKRDFMCXGID-MYSBRCAXSA-N
Formula C48H78O22
HBA 22
HBD 13
MW 1007.13
Rotatable Bonds 12
TPSA 346.06
LogP -3.01
Number Rings 9
Number Aromatic Rings 0
Heavy Atom Count 70
Formal Charge 0
Fraction CSP3 0.96
Exact Mass 1006.5
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Sansevieria cylindrica Dracaenaceae Plantae 13668

Showing of synonyms

  • Raslan M, Melek F, et al. (2017). New cytotoxic dihydrochalcone and steroidal saponins from the aerial parts of Sansevieria cylindrica Bojer ex Hook.. Phytochemistry Letters, 2017, 22, 39-43. [View]

No compound-protein relationship available.

Structure

SMILES: O1CCCCC1OCCCC(C2)OC3CC(C4C23)C5C(CC4)C6C(=CC5)CCCC6OC7OCCC(OC8CCCCO8)C7OC9CCCCO9

Level: 4

Mol. Weight: 1007.13 g/mol

Structure

SMILES: O1CCCCC1OCCCC(C2)OC3CC(C4C23)C5C(CC4)C6C(=CC5)CCCC6OC(OCCC7)C7OC8CCCCO8

Level: 3

Mol. Weight: 1007.13 g/mol

Structure

SMILES: O1CCCCC1OCCCC(C2)OC3CC(C4C23)C5C(CC4)C6C(=CC5)CCCC6OC(OCC7)CC7OC8CCCCO8

Level: 3

Mol. Weight: 1007.13 g/mol

Structure

SMILES: C1COC2CC(C3C12)C4C(CC3)C5C(=CC4)CCCC5OC6OCCC(OC7CCCCO7)C6OC8CCCCO8

Level: 3

Mol. Weight: 1007.13 g/mol

Structure

SMILES: O1CCCCC1OCCCC(C2)OC3CC(C4C23)C5C(CC4)C6C(=CC5)CCCC6OC7CCCCO7

Level: 2

Mol. Weight: 1007.13 g/mol

Structure

SMILES: C1COC2CC(C3C12)C4C(CC3)C5C(=CC4)CCCC5OC(OCCC6)C6OC7CCCCO7

Level: 2

Mol. Weight: 1007.13 g/mol

Structure

SMILES: C1COC2CC(C3C12)C4C(CC3)C5C(=CC4)CCCC5OC(OCC6)CC6OC7CCCCO7

Level: 2

Mol. Weight: 1007.13 g/mol

Structure

SMILES: O1CCCCC1OC2C(COCC2)OC3CCCCO3

Level: 2

Mol. Weight: 1007.13 g/mol

Structure

SMILES: O1CCCCC1OCCCC(C2)OC3CC(C4C23)C5C(CC4)C6C(=CC5)CCCC6

Level: 1

Mol. Weight: 1007.13 g/mol

Structure

SMILES: C1COC2CC(C3C12)C4C(CC3)C5C(=CC4)CCCC5OC6CCCCO6

Level: 1

Mol. Weight: 1007.13 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1007.13 g/mol

Structure

SMILES: C1COCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1007.13 g/mol

Structure

SMILES: C1COC2CC(C3C12)C4C(CC3)C5C(=CC4)CCCC5

Level: 0

Mol. Weight: 1007.13 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1007.13 g/mol

Cytotoxic

Absorption

Caco-2 (logPapp)
-6.58
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
38446.6
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
5025373.26

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.69
Plasma Protein Binding
11.54
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
2.06
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-116874.56
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-1.03
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-9120811604.8
Rat (Acute)
4.14
Rat (Chronic Oral)
20.1
Fathead Minnow
11513097.3
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
1025834373.36
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-561.73
Log(P)
-1.38
Log S
-2.26
Log(Vapor Pressure)
-33780051.27
Melting Point
243.88
pKa Acid
-246048.27
pKa Basic
-1968.11

No predicted protein targets found for this compound.

Download SDF